Test Price
2,500 AED✅ Home Collection Available
Glioma Prognostic Panel (NGS & PCR) – 2,500 AED | DNA Labs UAE
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) accredited molecular processing, compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 concerning the Use of Information and Communication Technology in Health Fields.
Premium Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval – FFPE block collection from your hospital with same-day delivery to our Dubai laboratory.
Clinical Guidance: Telephonic post-test clinical guidance and result interpretation by a DHA-licensed specialist.
Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Glioma Prognostic Panel combines PCR and Next Generation Sequencing (NGS) to analyze FFPE tumour tissue for critical prognostic and predictive biomarkers—including IDH1/2, TERT promoter, 1p/19q codeletion, and MGMT promoter methylation—directly impacting glioma subtyping and treatment planning.
| Feature | Our Glioma Prognostic Panel | Closest Alternative (Single-Gene Testing) |
|---|---|---|
| Precision | Multi‑marker NGS + PCR with derived ratios (e.g., 1p/19q), >99% analytical sensitivity | Limited to one or two markers, lower prognostic power |
| Method | NGS (Illumina®) + allele-specific PCR, ISO‑certified | FISH or single PCR |
| Speed | Report within 15 working days from FFPE block receipt by 11 am | Often >20 days with sequential testing |
Physician Insight & Safety Protocols
“Every glioma patient’s journey is unique. This prognostic panel deciphers the tumour’s molecular fingerprint, but the results must be interpreted together with your clinical presentation and imaging by a specialized neuro‑oncologist. Never make treatment changes without a multidisciplinary consultation.”
– Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA License: 61713011
Medication Advisory
Do not discontinue prescribed medication or alter your treatment plan without consulting your doctor.
Safety Exclusion Criteria & Red Flags
- Exclusion: FFPE tissue blocks with <5% viable tumour content or extensive necrosis may yield inconclusive results.
- Exclusion: Samples not properly fixed or stored at extreme temperatures may be rejected.
- ER Red Flags: If you experience sudden severe headache, seizure, or new neurological deficits after biopsy, seek emergency medical care immediately.
Patient FAQ & Clinical Guidance
1. What genetic markers are included in this panel?
The panel evaluates IDH1/2 mutations, TERT promoter mutations, 1p/19q codeletion, and MGMT promoter methylation. These biomarkers are critical for WHO glioma classification and help guide targeted therapies and clinical trial eligibility.
2. How long does it take to get results?
Results are typically reported within 15 working days after the FFPE tissue block is received by 11:00 AM. This includes sequencing, bioinformatics, and final pathologist review.
3. How is the sample collected?
Sample collection is performed only in a hospital setting during your biopsy or surgery. The FFPE block is then securely couriered to our laboratory. Mobile phlebotomy is not available for this test.
UAE Regulatory & Data Privacy Adherence
Our Commitment to Compliance
DNA Labs UAE operates under DHA Facility License No. 1143 and strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical procedures follow Federal Decree-Law No. 4 of 2016 on Medical Liability to ensure patient safety and informed consent.
Clinical & Logistical Metadata
| Test Name | Glioma Prognostic Panel (NGS & PCR) |
| Price (AED) | 2,500 |
| Turnaround Time | 15 working days from FFPE block receipt by 11:00 AM |
| Sample Type / Matrix | Archival Tissue Specimen (FFPE Tissue Block) – Secure Medical Courier Solid Tissue Specimen Retrieval |
| Methodology Used | Next Generation Sequencing (Illumina) & Allele-Specific PCR |
| ICD-10-CM Code | C71.9 |
| LOINC Code | 63332-3 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians